RNA Therapeutics for disease modification in neurological disorders NEUmiRNA Therapeutics is a Danish pharmaceutical start-up based in Copenhagen. Founded in 2020, NEUmiRNA focuses on achieving transformative disease modification for neurological conditions. Slide 1 Slide 1 (current slide) Slide 2 Slide 2 (current slide) Slide 3 Slide 3 (current slide) Slide 4 Slide 4 (current slide) Slide 5 Slide 5 (current slide)
